Randomized Study of Adjuvant Radiotherapy After Curative Resection of HCC With Narrow Margin (RAISE)
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Abbreviated MRI for HCC Surveillance
- Status
- UNKNOWN
- Phase
- NA
Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE
- Status
- UNKNOWN
- Phase
- NA
Irradiation Stent Placement Plus TACE for HCC and PVTT
- Status
- UNKNOWN
- Phase
- NA
SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery
- Status
- UNKNOWN
- Phase
- NA
The Assesment of MMP-1 Genotypes Polymorphism as a Risk Factor for HCC in Chronic HCV Patients With LC
- Status
- UNKNOWN
- Phase
- N/A
Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE
- Status
- WITHDRAWN
- Phase
- PHASE2
Liquid Biopsy-based Monitoring System for Relapse of HCC After Liver Transplantation: A Multi-center and Prospective Study
- Status
- UNKNOWN
- Phase
- N/A
Direct Acting Antiviral-Post Authorization Safety Study
- Status
- COMPLETED
- Phase
- N/A
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention
- Status
- COMPLETED
- Phase
- NA
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
- Status
- COMPLETED
- Phase
- N/A
Dual and Single Switching Monopolar RFA Using Separable Clustered Electrode for Treatment of HCC
- Status
- COMPLETED
- Phase
- NA
A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
- Status
- RECRUITING
- Phase
- NA
Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
[68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2